Azacytidine Monotherapy in an Infant With Mosaic NRAS-Driven Juvenile Myelomonocytic Leukemia.
作者信息
Grenier Jeremy M, Tasian Sarah K, Stieglitz Elliot, Abdullaev Zied, Wertheim Gerald B, Li Marilyn M, Phillips Charles A
机构信息
Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
出版信息
Pediatr Blood Cancer. 2025 May;72(5):e31647. doi: 10.1002/pbc.31647. Epub 2025 Mar 4.
Abstract
摘要
相似文献
1
Azacytidine Monotherapy in an Infant With Mosaic NRAS-Driven Juvenile Myelomonocytic Leukemia.阿扎胞苷单药治疗1例由嵌合型NRAS驱动的幼年型粒单核细胞白血病婴儿
Pediatr Blood Cancer. 2025 May;72(5):e31647. doi: 10.1002/pbc.31647. Epub 2025 Mar 4.
2
Acquisition of loss of the wild-type NRAS locus with aggressive disease progression in a patient with juvenile myelomonocytic leukemia and a heterozygous NRAS mutation.一名患有青少年粒单核细胞白血病且携带NRAS杂合突变的患者，在疾病进展迅速时出现野生型NRAS基因座缺失。
Haematologica. 2007 Nov;92(11):1576-8. doi: 10.3324/haematol.11503.
3
Early T-Cell Precursor Acute Lymphoblastic Leukemia in an Infant With an NRAS Q61R Mutation and Clinical Features of Juvenile Myelomonocytic Leukemia.一名患有NRAS Q61R突变的婴儿的早期T细胞前体急性淋巴细胞白血病及青少年型骨髓单核细胞白血病的临床特征
Pediatr Blood Cancer. 2016 Sep;63(9):1667-70. doi: 10.1002/pbc.26050. Epub 2016 May 4.
4
Novel approaches to diagnosis and treatment of Juvenile Myelomonocytic Leukemia.青少年骨髓单核细胞白血病的诊断和治疗新方法。
Expert Rev Hematol. 2018 Feb;11(2):129-143. doi: 10.1080/17474086.2018.1421937. Epub 2018 Jan 3.
5
A novel conditioning regimen involving haploid immune cell infusion combined with umbilical cord blood transplantation for the treatment of juvenile myelomonocytic leukemia.一种新型预处理方案，包括单倍体免疫细胞输注联合脐带血移植治疗青少年型骨髓单核细胞白血病。
Eur J Pediatr. 2025 Apr 2;184(5):274. doi: 10.1007/s00431-025-06109-5.
6
[Genetic and clinical characteristics of children with -mutated juvenile myelomonocytic leukemia].[-突变型青少年粒单核细胞白血病患儿的遗传及临床特征]
Zhongguo Dang Dai Er Ke Za Zhi. 2025 May 15;27(5):548-554. doi: 10.7499/j.issn.1008-8830.2411018.
7
Constitutional NRAS mutations are rare among patients with Noonan syndrome or juvenile myelomonocytic leukemia.在努南综合征或幼年骨髓单核细胞白血病患者中，NRAS 基因的结构突变较为罕见。
Am J Med Genet A. 2012 Oct;158A(10):2407-11. doi: 10.1002/ajmg.a.35513. Epub 2012 Aug 7.
8
Somatic mosaicism for oncogenic NRAS mutations in juvenile myelomonocytic leukemia.成神经细胞瘤 Ras 基因突变的体体细胞嵌合在幼年骨髓单核细胞性白血病中的作用。
Blood. 2012 Aug 16;120(7):1485-8. doi: 10.1182/blood-2012-02-406090. Epub 2012 Jul 2.
10
Panobinostat inhibits the proliferation of CD34 CD38 cells under stimulation of hematopoietic growth factors on AGM-S3 cells in juvenile myelomonocytic leukemia.帕比司他抑制了幼年粒单核细胞白血病 AGM-S3 细胞在造血生长因子刺激下 CD34+CD38+细胞的增殖。
Pediatr Blood Cancer. 2018 Nov;65(11):e27261. doi: 10.1002/pbc.27261. Epub 2018 Jul 16.
本文引用的文献
1
Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children's Oncology Group.变构 MEK 抑制剂曲美替尼治疗复发/难治性幼年髓单核细胞白血病的疗效：来自儿童肿瘤协作组的报告。
Cancer Discov. 2024 Sep 4;14(9):1590-1598. doi: 10.1158/2159-8290.CD-23-1376.
2
Clinical responses in pediatric patients with relapsed/refractory leukemia treated with azacitidine and venetoclax.接受阿扎胞苷和维奈克拉治疗的复发/难治性白血病儿科患者的临床反应
Haematologica. 2023 Nov 1;108(11):3142-3147. doi: 10.3324/haematol.2022.282637.
3
Juvenile myelomonocytic leukemia in the molecular era: a clinician's guide to diagnosis, risk stratification, and treatment.分子时代的青少年骨髓单核细胞白血病：诊断、风险分层和治疗的临床医生指南。
Blood Adv. 2021 Nov 23;5(22):4783-4793. doi: 10.1182/bloodadvances.2021005117.
4
Response to upfront azacitidine in juvenile myelomonocytic leukemia in the AZA-JMML-001 trial.AZA-JMML-001 试验中 upfront 阿扎胞苷治疗幼年型粒单核细胞白血病的疗效。
Blood Adv. 2021 Jul 27;5(14):2901-2908. doi: 10.1182/bloodadvances.2020004144.
5
Molecular and phenotypic diversity of CBL-mutated juvenile myelomonocytic leukemia.CBL 突变型幼年骨髓单核细胞白血病的分子和表型多样性。
Haematologica. 2022 Jan 1;107(1):178-186. doi: 10.3324/haematol.2020.270595.
6
International Consensus Definition of DNA Methylation Subgroups in Juvenile Myelomonocytic Leukemia.国际共识定义青少年骨髓单核细胞白血病中的 DNA 甲基化亚群。
Clin Cancer Res. 2021 Jan 1;27(1):158-168. doi: 10.1158/1078-0432.CCR-20-3184. Epub 2020 Nov 2.
7
Development and Clinical Validation of a Large Fusion Gene Panel for Pediatric Cancers.开发和临床验证用于儿科癌症的大型融合基因panel。
J Mol Diagn. 2019 Sep;21(5):873-883. doi: 10.1016/j.jmoldx.2019.05.006. Epub 2019 Jun 27.
8
Clinical utility of custom-designed NGS panel testing in pediatric tumors.定制化 NGS -panel 检测在儿科肿瘤中的临床实用性。
Genome Med. 2019 May 28;11(1):32. doi: 10.1186/s13073-019-0644-8.
9
Juvenile myelomonocytic leukemia: who's the driver at the wheel?幼年型粒单核细胞白血病：谁是掌舵人？
Blood. 2019 Mar 7;133(10):1060-1070. doi: 10.1182/blood-2018-11-844688. Epub 2019 Jan 22.
10
JMML genomics and decisions.JMML 的基因组学与决策。
Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):307-312. doi: 10.1182/asheducation-2018.1.307.
Zotero 插件